92 related articles for article (PubMed ID: 6117398)
1. Preliminary trial of clonidine treatment in two patients suffering from chronic schizophrenia.
Elizur A; Levy A; Lahav M; Blum I
Commun Psychopharmacol; 1980; 4(6):507-17. PubMed ID: 6117398
[No Abstract] [Full Text] [Related]
2. Do neuroleptics cause depression?
Roy A
Biol Psychiatry; 1984 May; 19(5):777-81. PubMed ID: 6145454
[TBL] [Abstract][Full Text] [Related]
3. Seroquel and cognitive improvement in patients with schizophrenia.
Stip E; Lussier I; Babai M; Fabian JL; Link C
Biol Psychiatry; 1996 Sep; 40(5):434-5. PubMed ID: 8874852
[No Abstract] [Full Text] [Related]
4. [Better prognosis due to new treatment approaches. Therapy of schizophrenia in 2002].
Janssen B; Gaebel W
MMW Fortschr Med; 2002 May; Suppl 2():72-6, 78. PubMed ID: 12070858
[TBL] [Abstract][Full Text] [Related]
5. Depressive symptoms and schizophrenia a psychopharmacological approach.
Mauri MC; Bravin S; Fabiano L; Vanni S; Boscati L; Invernizzi G
Encephale; 1995; 21(5):555-8. PubMed ID: 8529564
[TBL] [Abstract][Full Text] [Related]
6. Frontal lobe tasks, antipsychotic medication, and schizophrenia syndromes.
Himelhoch S; Taylor SF; Goldman RS; Tandon R
Biol Psychiatry; 1996 Feb; 39(3):227-9. PubMed ID: 8837987
[No Abstract] [Full Text] [Related]
7. [Presentation of obsessive-compulsive symptoms in a patient with schizophrenia treated with clozapine].
Stengler-Wenzke K
Psychiatr Prax; 1999 May; 26(3):145-6. PubMed ID: 10412713
[TBL] [Abstract][Full Text] [Related]
8. Piperacetazine in ambulatory chronic schizophrenic patients.
Rada RT; Donlon PT
Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665
[No Abstract] [Full Text] [Related]
9. The relationship of the brief psychiatric rating scale to neuropsychological deficits in phenothiazine-treated schizophrenics.
Golden CJ; Carpenter B; Wilkening G; Ruedrich S; Chu CC; Graber B
Psychopharmacol Bull; 1983; 19(3):513-7. PubMed ID: 6138799
[No Abstract] [Full Text] [Related]
10. A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia.
Salimi S; Fotouhi A; Ghoreishi A; Derakhshan MK; Khodaie-Ardakani MR; Mohammadi MR; Noorbala AA; Ahmadi-Abhari SA; Hajiazim M; Abbasi SH; Akhondzadeh S
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):726-32. PubMed ID: 18096287
[TBL] [Abstract][Full Text] [Related]
11. Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapine.
Friedman J; Ault K; Powchik P
Biol Psychiatry; 1997 Sep; 42(6):522-3. PubMed ID: 9285089
[No Abstract] [Full Text] [Related]
12. Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone.
Kopala LC; Fredrikson D; Good KP; Honer WG
Biol Psychiatry; 1996 Feb; 39(4):296-8. PubMed ID: 8645777
[No Abstract] [Full Text] [Related]
13. [Noncompliance--a typical problem in psychiatric patients. Individual, social and illness-specific factors].
Hartung HD
Fortschr Med; 1998 Jan; 116(3):28-30. PubMed ID: 9522542
[No Abstract] [Full Text] [Related]
14. Experience with a drug-free month in schizophrenic outpatients.
Heinrichs DW; Carpenter WT
Psychopharmacol Bull; 1985; 21(1):117-9. PubMed ID: 2858904
[No Abstract] [Full Text] [Related]
15. Efficacy and tolerance of D-cycloserine in drug-free schizophrenic patients.
van Berckel BN; Hijman R; van der Linden JA; Westenberg HG; van Ree JM; Kahn RS
Biol Psychiatry; 1996 Dec; 40(12):1298-300. PubMed ID: 8959296
[No Abstract] [Full Text] [Related]
16. ICI 204,636: a new atypical antipsychotic drug.
Hirsch SR; Link CG; Goldstein JM; Arvanitis LA
Br J Psychiatry Suppl; 1996 May; (29):45-56. PubMed ID: 8733823
[No Abstract] [Full Text] [Related]
17. Information processing and maintenance dose requirements in schizophrenia.
Marder SR; Asarnow RF; Van Putten T
Psychopharmacol Bull; 1988; 24(2):247-50. PubMed ID: 2905506
[No Abstract] [Full Text] [Related]
18. Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial.
Leiderman E; Zylberman I; Zukin SR; Cooper TB; Javitt DC
Biol Psychiatry; 1996 Feb; 39(3):213-5. PubMed ID: 8837983
[No Abstract] [Full Text] [Related]
19. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
[TBL] [Abstract][Full Text] [Related]
20. Factors which can make patients difficult to treat.
Kane JM
Br J Psychiatry Suppl; 1996 Dec; (31):10-4. PubMed ID: 8968650
[No Abstract] [Full Text] [Related]
[Next] [New Search]
